113 related articles for article (PubMed ID: 2815899)
21. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
Cordero L; Nankervis CA; Delooze D; Giannone PJ
J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986
[TBL] [Abstract][Full Text] [Related]
22. [Treatment with intravenous indomethacin of symptomatic ductus arteriosus in premature newborn infants].
Valls i Soler A; Benito J; Pastor E; López Heredia I; Santiago M; Cabrera A
An Esp Pediatr; 1987 Aug; 27(2):112-6. PubMed ID: 3662265
[TBL] [Abstract][Full Text] [Related]
23. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management.
Neu J; Ariagno RL; Johnson JD; Pitlick PT; Cohen RS; Beets CL; Sunshine P
Pediatr Pharmacol (New York); 1981; 1(3):245-9. PubMed ID: 7346744
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacologic treatment of patent ductus arteriosus in premature infants].
Vázquez C; Cabrera A; Pastor E; Valls y Soler A
An Esp Pediatr; 1983 Jun; 18(6):482-8. PubMed ID: 6625369
[TBL] [Abstract][Full Text] [Related]
25. [Changes of mechanics of breathing in newborns after pharmacological ligation of persistent ductus arteriosus (PDA)].
Szymankiewicz M; Gadzinowski J
Przegl Lek; 2002; 59 Suppl 1():25-7. PubMed ID: 12108067
[TBL] [Abstract][Full Text] [Related]
26. [Effects of early therapy with indomethacin on the manifestation of a persistent ductus arteriosus in extremely underweight premature infants].
Vogtmann C; Grubbe G; Ruckhäberle KE; Böttcher H; Ockert C
Monatsschr Kinderheilkd; 1988 Sep; 136(9):636-9. PubMed ID: 3070369
[TBL] [Abstract][Full Text] [Related]
27. Therapy of symptomatic patent ductus arteriosus in preterms using mefenemic acid and indomethacin.
Sakhalkar VS; Merchant RH
Indian Pediatr; 1992 Mar; 29(3):313-8. PubMed ID: 1612672
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
[TBL] [Abstract][Full Text] [Related]
29. Aspirin versus indomethacin treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome.
van Overmeire B; Brus F; van Acker KJ; van der Auwera JC; Schasfoort M; Elzenga NJ; Okken A
Pediatr Res; 1995 Dec; 38(6):886-91. PubMed ID: 8618789
[TBL] [Abstract][Full Text] [Related]
30. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.
Desfrere L; Zohar S; Morville P; Brunhes A; Chevret S; Pons G; Moriette G; Rey E; Treluyer JM
J Clin Pharm Ther; 2005 Apr; 30(2):121-32. PubMed ID: 15811164
[TBL] [Abstract][Full Text] [Related]
31. Surgical closure of patent ductus arteriosus in 268 preterm infants.
Wagner HR; Ellison RC; Zierler S; Lang P; Purohit DM; Behrendt D; Waldhausen JA
J Thorac Cardiovasc Surg; 1984 Jun; 87(6):870-5. PubMed ID: 6374300
[TBL] [Abstract][Full Text] [Related]
32. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
[TBL] [Abstract][Full Text] [Related]
33. Ibuprofen: alternative treatment for patent ductus arteriosus.
Flores M
Neonatal Netw; 2003; 22(2):27-31. PubMed ID: 12696723
[TBL] [Abstract][Full Text] [Related]
34. [Management of persistent ductus arteriosus in the newborn with respiratory insufficiency].
Hurtado del Rio D; Holden Barker AM; Pezzotti MA; Gutiérrez Bosque R; Archundia A; Pérez Mejia J; Carrillo H
Arch Inst Cardiol Mex; 1979; 49(4):662-72. PubMed ID: 485672
[TBL] [Abstract][Full Text] [Related]
35. B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus.
Attridge JT; Kaufman DA; Lim DS
Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F178-82. PubMed ID: 18981033
[TBL] [Abstract][Full Text] [Related]
36. Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates.
Katayama Y; Minami H; Enomoto M; Takano T; Hayashi S; Lee YK
J Perinatol; 2011 Jan; 31(1):21-4. PubMed ID: 20505743
[TBL] [Abstract][Full Text] [Related]
37. [Renal effects of prolonged indomethacin therapy in premature infants].
Gouyon JB; Chouchane M; Françoise M
Arch Pediatr; 1994 Oct; 1(10):894-7. PubMed ID: 7842069
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of intra-arterial indomethacin treatment for patent ductus arteriosus.
Weninger M; Pollak A; Salzer-Muhar U; Vergesslich KA; Salzer HR
Eur J Pediatr; 1989 Nov; 149(2):138-40. PubMed ID: 2591407
[TBL] [Abstract][Full Text] [Related]
39. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels.
O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM
Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317
[TBL] [Abstract][Full Text] [Related]
40. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
